Indeed, central nodes in the TMZ resistance network participate of the PI3K-Akt-mTOR and Ras-Raf-Erk pathways, major downstream pathways activated by growth factors during glioma progression20, 21. The gene discussed is AKT1; the disease is central nervous system cancer.